Next 10 |
2023-08-09 12:57:34 ET MedTech Acquisition Corp. ( NASDAQ: MTAC ) shareholders have voted in favor of the SPAC's planned merger with oncology products developer TriSalus Life Sciences. MTAC disclosed the vote in a filing. After the closing, shares of the combined company are...
MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without conducting any business, its special meeting of stockholders (the “Special Meeting”). The Special Meeting is being hel...
New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor DNA (ctDNA) levels TriSalus Life Sciences® Inc., (TriSalus or the Company), an oncology company in the process of going publi...
TriSalus Life Sciences ® , Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“...
The Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting. New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company&...
SPAC MedTech Acquisition ( NASDAQ: MTAC ) has agreed to take a privately held oncology therapeutics company, TriSalus Life Sciences, public in a reverse merger deal valued at $244.4M. TriSalus Life Sciences is focused on integrating immunotherapy with disruptive delive...
Two out of the three new deals announced last week were potential deals in the works. Google is paying $5.4 billion to acquire Mandiant. Four SPAC Business Combinations terminated last week. For further details see: Merger Arbitrage Mondays: Google Acquires Cybersecurity...
SPAC MedTech Acquisition Corp. (NASDAQ:MTAC) and Memic Innovative Surgery Ltd. said that they have agreed to terminate their planned merger due to market volatility and recent world events. The SPAC and Israeli medical device company had originally announced their intention to combine in Augu...
TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech”), a publicly traded special purpose acquisition company (SPAC) focused on medical technology, and Memic Innovative Surgery Ltd. (“Mem...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
News, Short Squeeze, Breakout and More Instantly...
MedTech Acquisition Corporation Company Name:
MTAC Stock Symbol:
NASDAQ Market:
MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without conducting any business, its special meeting of stockholders (the “Special Meeting”). The Special Meeting is being hel...
New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor DNA (ctDNA) levels TriSalus Life Sciences® Inc., (TriSalus or the Company), an oncology company in the process of going publi...
TriSalus Life Sciences ® , Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“...